Oxidative Medicine and Cellular Longevity / 2021 / Article / Tab 4 / Research Article
Gender-Specific Behaviour in Obesity Stages I-II: Imbalance of Aminothiol Status and Adipomyokine Profile in Subjects with Different Insulin Resistance Severity Table 4 Univariable logistic regression analysis for severe IR (
). ( ) ( )OR 95% CI Male gender, (%) 15 (43%) 14 (56%) 1.697 0.603-4.778 0.317 Plasma reduced homocysteine (μ mol/L) 0.27 [0.19-0.48] 0.20 [0.14-0.48] 0.276 0.035-2.187 0.223 Plasma total homocysteine (μ mol/L) 10.36 [7.86-14.54] 12.66 [9.18-15.06] 1.071 0.956-1.199 0.235 Plasma oxidized homocysteine (μ mol/L) 9.97 [7.82-14.35] 12.53 [9.05-14.71] 1.083 0.963-1.217 0.184 Plasma reduced cysteine (μ mol/L) 10.97 [9.10-13.65] 10.14 [8.84-13.55] 0.940 0.795-1.112 0.472 Plasma total cysteine (μ mol/L) 278 [251-321] 331 [274-391] 1.012 1.003-1.021 0.010 Plasma oxidized cysteine (μ mol/L) 265 [238-308] 320 [267-380] 1.012 1.003-1.021 0.009 Plasma reduced glutathione (μ mol/L) 1.30 [0.97-1.58] 0.89 [0.63-1.62] 0.598 0.259-1.380 0.228 Plasma total glutathione (μ mol/L) 4.33 [3.76-4.80] 4.63 [3.41-5.44] 1.176 0.777-1.779 0.443 Plasma oxidized glutathione (μ mol/L) 2.72 [2.46-3.50] 2.93 [2.46-4.47] 1.460 0.908-2.350 0.118 Leptin (ng/mL) 13.60 [5.30-23.70] 18.80 [12.65-27.20] 1.053 1.003-1.105 0.036 Adiponectin (μ g/mL) 14.73 [10.80-22.82] 12.69 [10.42-17.33] 0.903 0.819-0.995 0.039 Myostatin (ng/mL) 10.47 [8.27-12.84] 11.60 [10.23-15.31] 1.080 0.952-1.226 0.231 Interleukin-6 (pg/mL) 1.94 [1.21-2.38] 2.54 [1.95-3.38] 1.814 1.133-2.905 0.013 Vitamin D (ng/mL) 26 [21-30] 18 [14-32] 0.994 0.885-1.007 0.078
Referent category =
. HOMA: homeostasis model assessment; OR: odds ratio; CI: confidence interval.